ClinicalTrials.gov record
Recruiting Phase 2 Interventional

TNF-α Treatment of Blast-Induced Tinnitus

ClinicalTrials.gov ID: NCT04066348

Public ClinicalTrials.gov record NCT04066348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Trial of Etanercept (TNF-α Blocker) for Treatment of Blast-Induced Tinnitus

Study identification

NCT ID
NCT04066348
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Wayne State University
Other
Enrollment
88 participants

Conditions and interventions

Interventions

  • Etanercept Biological
  • Saline Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2022
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026
Last update posted
Feb 22, 2026

2022 – 2026

United States locations

U.S. sites
4
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
Advent Health Celebration Florida 34747 Recruiting
University of Miami Coral Gables Florida 33124 Recruiting
Wayne State University Detroit Michigan 48201 Recruiting
Michigan Ear Institute Farmington Hills Michigan 48334 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04066348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04066348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →